StockNews.com Initiates Coverage on Arcadia Biosciences (NASDAQ:RKDA)

Investment analysts at StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a report released on Saturday. The firm set a “sell” rating on the basic materials company’s stock.

Arcadia Biosciences Price Performance

Shares of RKDA stock opened at $3.32 on Friday. Arcadia Biosciences has a 1-year low of $1.85 and a 1-year high of $10.31. The business’s fifty day moving average price is $4.53 and its 200 day moving average price is $4.11. The firm has a market capitalization of $4.54 million, a PE ratio of -0.78 and a beta of 0.86.

Institutional Trading of Arcadia Biosciences

An institutional investor recently bought a new position in Arcadia Biosciences stock. Geode Capital Management LLC purchased a new stake in shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA) in the fourth quarter, according to its most recent filing with the SEC. The firm purchased 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned 0.90% of Arcadia Biosciences at the end of the most recent quarter. 17.73% of the stock is owned by institutional investors and hedge funds.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.